What’s Going On With Rocket Lab Stock?

Rocket Lab (RKLB)’s shares soared over 100% since mid-May, driven not only by consistent revenue growth but also by a near doubling in investor optimism.

JIUQUAN, CHINA – SEPTEMBER 29: A Long March 2F rocket carrying the country’s first space laboratory module Tiangong-1 lifts off from the Jiuquan Satellite Launch Center on September 29, 2011 in Jiuquan, Gansu province of China. The unmanned Tiangong-1 will stay in orbit for two years and dock with China’s Shenzhou-8, -9 and -10 spacecraft with the eventual goal of establishing a manned Chinese space station around 2020. (Photo by Lintao Zhang/Getty Images)

Getty Images

Contributing to this spike were factors such as a strong earnings performance, ambitious growth projections, a strategic purchase, and record-setting orders. That being said, the stock has seen a bit of a sell-off over the past month, falling by over 20% amid reports that the inaugural flight of its reusable Neutron rocket would be delayed from a previously targeted launch date in late 2025 to sometime in 2026, to enable more testing and qualification work.

Let’s break down what truly influenced the stock’s surge in recent months.

So what is happening here? The stock price increased by 103%, propelled by an 8.2% increase in revenue and a 91% rise in the P/S multiple. Let’s delve into the significant events that have driven these remarkable changes.

Before we examine the details of the incidents that resulted in the stock surge, let’s consider what market wisdom suggests: while investing in a single stock can be precarious, there is considerable merit in a more expansive and diversified strategy, such as the one we employ with the Trefis High Quality Portfolio. Trefis collaborates with Empirical Asset Management — a wealth manager based in the Boston area — whose asset allocation methods yielded positive returns during the 2008-09 period when the S&P experienced losses exceeding 40%. Empirical has integrated the Trefis HQ Portfolio into this asset allocation framework to deliver enhanced returns to clients while minimizing risk compared to the benchmark index.

Here Is Why Rocket Lab Stock Moved

• Q3 Earnings Beat: Record Q3 2025 revenue of $155.08M, experiencing 48% YoY growth and exceeding estimates with a reduced net loss.
• Strong Q4 Guidance: The company issued robust Q4 2025 revenue guidance of $170-180M, enhancing investor confidence.
• Geost Acquisition: The acquisition of Geost for up to $325M was completed, enhancing national security capabilities.
• Record Electron Orders: Secured a record 17 Electron launch contracts in Q3 2025, resulting in a backlog exceeding $1.1B.

Our Current Assessment Of RKLB Stock

Opinion: At present, we consider RKLB stock to be relatively overpriced. Why is that? Take a look at the complete story. Read Buy or Sell RKLB Stock to understand the rationale behind our current viewpoint.

Risk: A practical way to evaluate RKLB’s risk is to observe its decline during significant market crises. It only fell about 3% during the Covid pandemic, which is relatively mild. However, during the inflation shock, the stock tumbled more than 82%. That’s a substantial setback, indicating that despite positive elements, RKLB can still undergo severe declines under adverse market conditions. Even with optimistic forecasts, volatility is a genuine concern for this stock.

While RKLB stock may have experienced notable gains lately, investing in a single stock without comprehensive analysis can be hazardous. The Trefis High Quality (HQ) Portfolio, consisting of 30 stocks, has a history of consistently outperforming its benchmark, which includes all three — the S&P 500, S&P mid-cap, and Russell 2000 indices. What accounts for this? As a collective, HQ Portfolio stocks have delivered superior returns with reduced risk relative to the benchmark index; offering a smoother investment experience, as demonstrated in HQ Portfolio performance metrics.